These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 742039)

  • 21. Combination therapy with mitoxantrone and etoposide in refractory acute myelogenous leukemia.
    Ho AD; Lipp T; Ehninger G; Meyer P; Freund M; Hunstein W
    Cancer Treat Rep; 1986 Aug; 70(8):1025-7. PubMed ID: 3460698
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Proceedings: Management of acute leukemia.
    Freireich EJ; Bodey GP; McCredie KB; Rodriguez V; Hart JS; Burgess MA; Gutterman JU
    Proc Natl Cancer Conf; 1972; 7():345-9. PubMed ID: 4764911
    [No Abstract]   [Full Text] [Related]  

  • 23. [Side effects of the drug therapy of leukemia].
    Lorie I; Khvatova NV
    Klin Med (Mosk); 1975 May; 52(5):135-9. PubMed ID: 1133987
    [No Abstract]   [Full Text] [Related]  

  • 24. [Therapy of acute leukemia. 4. Remission induction and remission maintenance therapy].
    Hirano M; Uetani T; Morita A; Sako F; Koie K
    Saishin Igaku; 1971 Oct; 26(10):2034-41. PubMed ID: 5288692
    [No Abstract]   [Full Text] [Related]  

  • 25. [Treatment of acute leukoses at the Internal Clinic of the Dr. Z. Kucic Hospital in Rjeka].
    Premuzić-Lampic M
    Bilt Hematol Transfuz; 1976; 4(1-2):53-4. PubMed ID: 1066126
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Acute monocytic leukemia and acute myelomonocytic leukemia: treatment using VP 16213].
    Amiel JL; Schwarzenberg L; Musset M; De Vassal F; Hayat M; Mathé G
    Bull Cancer; 1974; 61(3):419-26. PubMed ID: 4533742
    [No Abstract]   [Full Text] [Related]  

  • 27. Daunorubicin-prednisone in the treatment of acute nonlymphocytic leukemia.
    Peterson BA; Bloomfield CD; Theologides A; Kennedy BJ
    Cancer Treat Rep; 1981; 65 Suppl 4():29-33. PubMed ID: 6955011
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Initial results with a epipodophyllotoxin derivative VP 16-213 in the treatment of acute leukemia].
    Cavalli F; Ryssel HJ; Batz K; Sonntag RW; Brunner KW
    Schweiz Med Wochenschr; 1975 Feb; 105(8):250-3. PubMed ID: 1054886
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [High-dose cytosine arabinoside therapy in refractory acute leukemia].
    Yorimitsu S; Takahashi I; Kitazima K; Kimura I; Hara M; Tokuda M
    Rinsho Ketsueki; 1984 Dec; 25(12):1941-6. PubMed ID: 6533329
    [No Abstract]   [Full Text] [Related]  

  • 30. In vivo cellular kinetic and pharmacological studies of 1-beta-D-arabinofuranosylcytosine and 3-deazauridine chemotherapy for relapsing acute leukemia.
    Barlogie B; Plunkett W; Raber M; Latreille J; Keating M; McCredie K
    Cancer Res; 1981 Mar; 41(3):1227-35. PubMed ID: 7459863
    [No Abstract]   [Full Text] [Related]  

  • 31. Mitoxantrone in patients with acute leukemia in relapse.
    Paciucci PA; Ohnuma T; Cuttner J; Silver RT; Holland JF
    Cancer Res; 1983 Aug; 43(8):3919-22. PubMed ID: 6861154
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Treatment of acute leukemia in the phase of complete remission].
    Kovaleva LG; Isaev VG
    Probl Gematol Pereliv Krovi; 1976 Jul; 21(7):9-13. PubMed ID: 1071795
    [No Abstract]   [Full Text] [Related]  

  • 33. [Acute adult leukemia. Therapeutic options including supportive measures].
    Jehn U; Wilmanns W
    MMW Munch Med Wochenschr; 1980 Apr; 122(14):494-8. PubMed ID: 6769025
    [No Abstract]   [Full Text] [Related]  

  • 34. Serial studies of immunocompetence of patients undergoing chemotherapy for acute leukemia.
    Hersh EM; Gutterman JU; Mavligit GM; McCredie KB; Burgess MA; Matthews A; Freireich EJ
    J Clin Invest; 1974 Aug; 54(2):401-8. PubMed ID: 4527189
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Phase I--II study of 3-deazauridine in adults with acute leukemia.
    Yap BS; McCredie KB; Keating MJ; Bodey GP; Freireich EJ
    Cancer Treat Rep; 1981; 65(5-6):521-4. PubMed ID: 7237473
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Treatment of acute leukemias].
    Brilliant MD
    Ter Arkh; 1973 Sep; 45(9):72-85. PubMed ID: 4585646
    [No Abstract]   [Full Text] [Related]  

  • 37. Methods for evaluating response to treatment in adult acute leukemia.
    Freireich EJ
    Blood Cells; 1983; 9(1):5-20. PubMed ID: 6344935
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Induction of remission by sequential treatment with cytosine arabinoside (araC/high dose) and L-asparaginase].
    Martín-Aragonés G; Sanz MA; Martínez JA; Rafecas FJ; Gomis F; Lorenzo I; Sanz G; Marty ML
    Sangre (Barc); 1985; 30(1):15-21. PubMed ID: 3859023
    [No Abstract]   [Full Text] [Related]  

  • 39. A randomized, postremission comparison of four courses of standard-dose consolidation therapy without maintenance therapy versus three courses of standard-dose consolidation with maintenance therapy in adults with acute myeloid leukemia: the Japan Adult Leukemia Study Group AML 97 Study.
    Miyawaki S; Sakamaki H; Ohtake S; Emi N; Yagasaki F; Mitani K; Matsuda S; Kishimoto Y; Miyazaki Y; Asou N; Matsushima T; Takahashi M; Ogawa Y; Honda S; Ohno R;
    Cancer; 2005 Dec; 104(12):2726-34. PubMed ID: 16284985
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Tallimustine, an effective antileukemic agent in a severe combined immunodeficient mouse model of adult myelogenous leukemia, induces remissions in a phase I study.
    Beran M; Jeha S; O'Brien S; Estey E; Vitek L; Zurlo MG; Rios MB; Keating M; Kantarjian H
    Clin Cancer Res; 1997 Dec; 3(12 Pt 1):2377-84. PubMed ID: 9815637
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.